Management of Intermittent Tachycardia and Hypertension in Dialysis Patients

Patient Assessment and Monitoring

• The patient is experiencing intermittent tachycardia (heart rate frequently >100 bpm) and episodes of hypertension while on dialysis three times weekly, with blood pressure readings showing fluctuations and some elevated readings 1, 2, 3
• Monitor blood pressure before, during, and after dialysis sessions, with a target heart rate of 55-60 beats per minute and systolic blood pressure not decreasing below 90 mmHg 1, 5, 6

Medication Management

• The American College of Cardiology recommends carvedilol as the preferred beta-blocker for dialysis patients with cardiovascular issues, due to its additional alpha-blocking properties and favorable pharmacokinetic profile 1, 2
• The recommended starting dose of carvedilol for hypertension in dialysis patients is 6.25 mg BID, with titration to 12.5-25 mg BID as needed, and a target dose of 25-50 mg BID for patients with heart failure 1, 4

Special Considerations

• Beta-blockers should not be abruptly discontinued in dialysis patients due to risk of rebound hypertension 6
• Ensure proper dry weight assessment and adequate ultrafiltration during dialysis sessions, as volume overload is a common cause of hypertension in dialysis patients 1

Alternative Approaches

• If the patient cannot tolerate an increased dose of carvedilol, consider adding a calcium channel blocker as these have been associated with decreased cardiovascular mortality in dialysis patients 3
• For resistant hypertension in dialysis patients, a combination of different classes of antihypertensive medications may be required 3